Wednesday, December 4, 2024
HomeFunding NYC-based ProofPilot Secures Series C Funding

[Funding News] NYC-based ProofPilot Secures Series C Funding

ProofPilot, a leading Clinical Experience Platform (CXP), announced the closing of its Series C financing, led by Sopris Capital with Mitsui & Co. (U.S.A.), Inc. participating. Founded in 2014, ProofPilot was one of the first global digital clinical trial solutions allowing virtual, hybrid, and in-person research offerings with patient and site Co-Pilot packages.

ProofPilot, a leading Clinical Experience Platform (CXP), announced the closing of its Series C financing, led by Sopris Capital with Mitsui & Co. (U.S.A.), Inc. participating. Founded in 2014, ProofPilot was one of the first global digital clinical trial solutions allowing virtual, hybrid, and in-person research offerings with patient and site Co-Pilot packages.

Read also – [Funding News] CA-based Armada Raises $40M in Strategic Funding

ProofPilot’s platform, StudyCoPilot, centralizes and simplifies communication for sponsors, patients, and sites across the clinical trial experience. The products and services support key initiatives like improving DE&I, streamlining recruitment & retention, and easing site burden. ProofPilot has scaled its capabilities for enterprise use and has industry leading pharmaceutical clients deploying StudyCoPilot globally.

Read also – [Funding News] Buildots Secures $15M Funding From Intel Capital

“Much of the focus in clinical trial technology has been on data capture and AI, but supporting the clinical trial experience for stakeholders has taken a backseat,” said Chris Venezia, CEO of ProofPilot. “Our strategic advisory board, comprising patients, research sites, and sponsors, is solving the right challenges and needs to modernize experiences for all stakeholders. This repeat investment from our Series B investors recognizes the market’s need and provides us with resources to scale and accelerate life-saving therapies.”

“The sky is the limit with ProofPilot, and we are excited about investing in the company. We have tremendous confidence in the team and are proud to see some of the world’s leading life sciences companies adopt the technology,” said Abinav Sankar, Partner at Sopris Capital.

About ProofPilot

ProofPilot enhances clinical trials with its Clinical Experience Platform (CXP). The StudyCoPilot platform centralizes and simplifies communication for sponsors, patients, and sites across the clinical trial experience. ProofPilot supports clinical trials with the industry’s first fully automated digital protocol platform for recruitment and conduct. ProofPilot platform orchestrates stakeholder tasks and optimizes clinical workflows, improving recruitment efficiency, stakeholder experiences and data quality. The elimination of guesswork and research protocol deviations creates high-performance experiences for sites and patients.

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular